Arlettaz A, Le Panse B, Portier H, Lecoq A-M, Thomasson R, De Ceaurriz J, Collomp K
Laboratoire Activité Motrice et Adaptation Psychophysiologique, UFR STAPS, Université d'Orléans, 2, Allée du Château, BP6237, 45062 Orléans Cedex 2, France.
Eur J Appl Physiol. 2009 Jan;105(2):207-13. doi: 10.1007/s00421-008-0891-7. Epub 2008 Oct 17.
In order to test the hypothesis that salbutamol would change substrate oxidation during submaximal exercise, eight recreationally trained men twice performed 1 h at 60% VO(2) peak after ingestion of placebo or 4 mg of salbutamol. Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, insulin, and blood glucose and lactate determination. With salbutamol versus placebo, there was no significant difference in total energy expenditure and substrate oxidation, but the substrate oxidation balance was significantly modified after 40 min of exercise. ACTH was significantly decreased with salbutamol during the last 10 min of exercise, whereas no difference was found between the two treatments in the other hormonal and metabolic parameters. The theory that the ergogenic effect of salbutamol results from a change in substrate oxidation has little support during relatively short term endurance exercise, but it is conceivable that longer exercise duration can generate positive findings.
为了验证沙丁胺醇会在次最大运动期间改变底物氧化的假说,八名经过休闲训练的男性在摄入安慰剂或4毫克沙丁胺醇后,两次以60%的最大摄氧量(VO₂peak)进行了1小时运动。运动期间监测气体交换,并采集血样以测定生长激素(GH)、促肾上腺皮质激素(ACTH)、胰岛素、血糖和乳酸。与安慰剂相比,沙丁胺醇组的总能量消耗和底物氧化无显著差异,但运动40分钟后底物氧化平衡发生了显著改变。运动最后10分钟,沙丁胺醇组的ACTH显著降低,而在其他激素和代谢参数方面,两种处理之间未发现差异。在相对短期的耐力运动中,沙丁胺醇的促力作用源于底物氧化变化这一理论几乎没有依据,但可以想象,更长的运动持续时间可能会产生阳性结果。